Triglav Investments, D.o.o. »

Protagonist Therapeutics shares owned by Triglav Investments, D.o.o.

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Triglav Investments, D.o.o. from 13F filings

Historical chart of Triglav Investments, D.o.o. investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Triglav Investments, D.o.o. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Triglav Investments, D.o.o.

Quarter filed Position value Share count Share price at filing
2026-06-30 $368k 3.0k 122.58

More positions owned by Triglav Investments, D.o.o.

Nvidia Corporation Common (NVDA)
Amazon.com Common (AMZN)
Microsoft Corporation Common (MSFT)
Apple Common (AAPL)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Broadcom Common (AVGO)
Eli Lilly And Company Common (LLY)
Jpmorgan Chase & Co. Common (JPM)
Advanced Micro Devices Common (AMD)
Goldman Sachs Group Inc/the Common (GS)
Meta Platforms Common (META)
Taiwan Semiconductor Manufacturing Common (TSM)
Lam Research Corporation Common (LRCX)
Alphabet Common (GOOG)

View all positions for Triglav Investments, D.o.o.

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
UBS Group
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics